Evidence map›Paper›PMID 42554705›Full record

ReviewEndocrine-related cancer2026

Artificial intelligence in pituitary surgery: the path to clinical solutions.

George Hudson, Danyal Z Khan, Stephanie E Baldeweg, Hani J Marcus

Abstract readReview
In one paragraph

Review in Endocrine-related cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

George HudsonVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery , London, UK.ORCID 0000-0003-2506-6965
Danyal Z KhanVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery , London, UK.
Stephanie E BaldewegDepartment of Endocrinology, UCLH , London, UK.
Hani J MarcusVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery , London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is rapidly moving from conceptual innovation to high-performing algorithms across the pituitary patient pathway, promising benefits to patients, endocrinologists and surgeons alike. Pre-operatively, machine learning applied to facial imaging and natural language processing of electronic health records show potential for earlier identification of pituitary adenomas and timelier referral from primary providers to a specialist endocrinologist. Intraoperatively, computer vision systems have already augmented surgical training but have the potential to become integrated real-time decision support systems. Post-operatively, predictive models may help to forecast complications and longer-term remission, endocrinological outcomes or recurrence. Across these domains, the emergence of large, multimodal datasets, which integrate clinical text, endocrinological investigations, radiological imaging, and intraoperative video, promises further AI improvements, yet the impact of AI on real-world clinical decision-making is less clear and depends as much on implementation processes and clinicians themselves. This review provides an overview of AI technologies for pituitary patients and explores some of the challenges translating them to clinical practice.

Indexed as

Artificial IntelligencePituitary GlandPituitary NeoplasmsAdenomaHumansSoft Computingadenomaneuroendocrine tumourspituitary

Identifiers

PMID42554705
PMCPMC13506539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.